11,28,000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 2.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shelter Pharma Ltd has allotted 11,28,000 equity shares (face value ₹10 each) following the conversion of an equivalent number of fully paid convertible warrants, originally issued via preferential allotment on August 6, 2025 at ₹42.25 per warrant. The company received the balance 75% exercise price of ₹31.6875 per share, totalling ₹3.57 crore. As a result, paid-up equity capital rose from ₹12.87 crore (1.28 crore shares) to ₹14.00 crore (1.40 crore shares). The allottees include 2 promoter group members and 3 non-promoter individuals, with no remaining warrants outstanding from this tranche.
This is a routine warrant-to-equity conversion that increases the share count by about 8.8%, leading to mild dilution for existing shareholders. No fresh capital beyond what was already committed is being raised, so the immediate impact on stock price is expected to be limited.